HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$2.48B
1-Year Return
14.59%
This Quarter Return
-6.9%
1 Year Return
+14.59%
3 Year Return
+61.58%
5 Year Return
–
10 Year Return
–
AUM
$1.88B
AUM Growth
-$154M
(-7.6%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
16.6%
Holding
823
New
81
Increased
382
Reduced
295
Closed
54
Top Buys
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$16.7M |
| 2 |
Vanguard S&P Small-Cap 600 ETF
VIOO
|
+$9.8M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$8.86M |
| 4 |
SPDR Blackstone Senior Loan ETF
SRLN
|
+$3.89M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$3.23M |
Top Sells
| 1 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$13.6M |
| 2 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$9.25M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$4.19M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$4.08M |
| 5 |
Amazon
AMZN
|
+$3.68M |
Sector Composition
| 1 | Healthcare | 14.25% |
| 2 | Technology | 10.56% |
| 3 | Financials | 10.31% |
| 4 | Industrials | 5.46% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $1.89M | 0.1% |
146,089
-5,258
| -3% | -$67.9K |
|
227
Southern Company
SO
$100B
| $1.87M | 0.1% |
25,729
+1,497
| +6% | +$109K |
|
228
iShares International Select Dividend ETF
IDV
$5.78B
| $1.85M | 0.1% |
58,321
-5,371
| -8% | -$171K |
|
229
Citizens Financial Group
CFG
$22.3B
| $1.85M | 0.1% |
40,799
-25,740
| -39% | -$1.17M |
|
|
BBBY
230
Bed Bath & Beyond, Inc.
BBBY
$638M
| $1.83M | 0.1% |
41,566
+16,032
| +63% | +$705K |
|
231
Teradyne
TER
$18.3B
| $1.83M | 0.1% |
15,435
+375
| +2% | +$44.3K |
|
|
RVNC
232
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.82M | 0.1% |
93,156
-3,353
| -3% | -$65.4K |
|
|
BSCO
233
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $1.81M | 0.1% |
85,924
-3,198
| -4% | -$67.4K |
|
234
Equinix
EQIX
$76.3B
| $1.8M | 0.1% |
2,423
-951
| -28% | -$705K |
|
235
TTEC Holdings
TTEC
$182M
| $1.8M | 0.1% |
21,782
-78
| -0.4% | -$6.44K |
|
236
3M
MMM
$81.5B
| $1.8M | 0.1% |
14,425
+856
| +6% | +$107K |
|
237
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$3.04B
| $1.79M | 0.1% |
85,452
-2,589
| -3% | -$54.1K |
|
238
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.24B
| $1.79M | 0.09% |
85,102
-5,407
| -6% | -$113K |
|
239
Nektar Therapeutics
NKTR
$924M
| $1.78M | 0.09% |
21,954
+1,312
| +6% | +$106K |
|
|
ICPT
240
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.77M | 0.09% |
108,984
-4,264
| -4% | -$69.4K |
|
241
Global X SuperIncome Preferred ETF
SPFF
$135M
| $1.77M | 0.09% |
158,444
-12,040
| -7% | -$134K |
|
|
ATVI
242
DELISTED
Activision Blizzard Inc.
ATVI
| $1.73M | 0.09% |
21,537
-8,707
| -29% | -$697K |
|
243
Williams Companies
WMB
$70.3B
| $1.72M | 0.09% |
51,465
+1,590
| +3% | +$53.1K |
|
244
VanEck Emerging Markets High Yield Bond ETF
HYEM
$414M
| $1.71M | 0.09% |
84,544
-458
| -0.5% | -$9.24K |
|
|
AIF
245
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $1.7M | 0.09% |
118,394
+47,868
| +68% | +$687K |
|
|
CCXI
246
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.7M | 0.09% |
67,790
+11,447
| +20% | +$287K |
|
247
Arcutis Biotherapeutics
ARQT
$2.15B
| $1.68M | 0.09% |
87,369
+22,021
| +34% | +$424K |
|
248
Exelixis
EXEL
$10.3B
| $1.64M | 0.09% |
72,473
-3,646
| -5% | -$82.7K |
|
249
Heron Therapeutics
HRTX
$199M
| $1.62M | 0.09% |
283,954
-12,098
| -4% | -$69.2K |
|
250
SLR Investment Corp
SLRC
$911M
| $1.62M | 0.09% |
89,437
+34,727
| +63% | +$629K |
|